Aventis and Avalon Form Oncology Collaboration
Avalon to utilize molecular cytogenetics to identify and validate oncology targets
18-Dec-2003 -
Aventis and Avalon Pharmaceuticals, Inc., have entered into an agreement to collaborate on the identification, discovery and validation of drugable screening targets. As part of the agreement, Avalon will provide Aventis with a subset of its library of more than 200 identified amplicons (regions ...
Aventis
cytogenetics
drug development
+5